- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02690675
Iron Supplement Effect on Child Development
Iron Supplement Effect Over Immune System and Neurobehavioral Child Development.
Objective: To evaluate the effect of Iron supplement with two different amounts (one in the higher limit and another in the lower limit of the suggested amount) according to the presence of mutations in the HFE gene in the physical, immune and neurobehavioral development in the 6 to 12 moth toddlers.
Methodology: Subjects: 340 toddlers coming from Paediatric Serves of Sant Joan Hospital. Methods: At 6 and 12 months it done clinical history, food registry, biochemist determinations: haemoglobin, iron, transferrin, ferritin, reactive C protein and immune response (IL4, IL10, IL6 IFN, IgA, IgM, IgG, IgE). Mutations in the HFE gene: C282Y, H63D, S65D and hepcidin gene. Mental, psychomotor and behavioual development (Bayley Scales of Infant Development 2on Edition: 1993). We evaluate the level of language and communication (MacArthur), regulation and sensory process (Infant Toddler Symptom Checklist), familiar and environment surroundings (Scale Health General Parental Stress Index).
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Design: Randomised Clinical Trial with two groups of intervention. Group A received high-iron fortified milk (1.2mg/100mL) and Group B received low-iron fortified milk (0.4mg/100mL).
Inclusion criteria: caucasian new-borns, term infants.
Exclusion criteria:
- Families that refuse enter at the follow-up.
- Low-birth weight or preterm infants.
- Anaemic infants.
- Infants with congenital defects, immunodeficiency or hypothyroidism.
- Infants with diseases that requires intensive care.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Caucasian infants
- Healthy term infants
Exclusion Criteria:
- Families that do not understand Spanish or Catalan
- Anaemic infants at birth
- Infants with important diseases
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention high-iron fortified milk
This group received a high dose of iron by formula milk (1.2mg/100mL) between 6 and 12 months of age.
|
One group received formula milk fortified with 1.2 mg/100 mL and the other group 0.4 mg/100mL between 6 and 12 months of age.
|
|
Experimental: Intervention low-iron fortified milk
This group received a low dose of iron by formula milk (0.4mg/100mL) between 6 and 12 months of age.
|
One group received formula milk fortified with 1.2 mg/100 mL and the other group 0.4 mg/100mL between 6 and 12 months of age.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Mental and psychomotor development with BSID (Bayley Scale of Infant Development) at 12 months.
Time Frame: 12 months
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Height at 12 months measured in centimeters
Time Frame: 12 months
|
12 months
|
|
Weight at 12 months measured in grams
Time Frame: 12 months
|
12 months
|
|
Head circumference at 12 months measured in centimeters
Time Frame: 12 months
|
12 months
|
|
Risk of infections at 12 months measured qualitatively from record of presence or not of various infections as bronchitis, rhinitis, otitis etc.
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Victoria Arija Val, Professor, University Rovira i Virgili
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EC81/00128
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neurodevelopmental Disorders
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker Cochin; Fondation Perce NeigeNot yet recruitingNeurodevelopmental Disorders With Severe Self-injuriesFrance
-
University of SevilleRecruitingNeurodevelopmental Disorders | Neurodevelopmental Disorders and Developmental AbnormalitiesSpain
-
University Hospital, Clermont-FerrandNot yet recruitingNeurodevelopmental Disorder (Diagnosis)France
-
University of Missouri-ColumbiaCompletedChildren With Neurodevelopmental DisordersUnited States
-
IRCCS Eugenio MedeaRecruitingNeurodevelopmental Disorder (Diagnosis)Italy
-
Haute Ecole Ilya PrigogineNot yet recruitingNeurodevelopmental Disorders
-
University Hospital, ToursInstitut National de la Santé Et de la Recherche Médicale, FranceNot yet recruitingNeurodevelopmental Disorders
-
IRCCS Centro Neurolesi Bonino PulejoRecruitingNeurodevelopmental DisordersItaly
-
Aiyoudong Children and Youth Sports Health Research...Not yet recruitingNeurodevelopmental DisordersChina
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingFetal Neurodevelopmental Disorder | Cavum Septum PellucidumItaly
Clinical Trials on Iron fortified formula milk
-
Société des Produits Nestlé (SPN)Food and Nutrition Research Institute, Philippines; ETH Zurich (Switzerland)Completed
-
National Center for Research Resources (NCRR)Baylor College of MedicineCompletedSepsis | Necrotizing EnterocolitisUnited States
-
Umeå UniversityUniversity of California, Davis; Swiss Federal Institute of TechnologyCompletedInfant | Dietary Supplements | Food, FortifiedSweden
-
Huilian ZhuNot yet recruiting
-
Huilian ZhuNot yet recruiting
-
Gadjah Mada UniversityUnknown
-
Instituto de Desarrollo e Investigaciones Pediátricas...Hospital Interzonal de Agudos General San MartínRecruiting
-
Abbott NutritionCompleted
-
Carol HenryMarywood University; Brac; Nutrition InternationalUnknownIron-deficiency | Anemia, Iron-Deficiency | Cognitive PerformanceBangladesh
-
University of California, San FranciscoUniversity of California, DavisSuspendedMicrobial Colonization | Breastfeeding | Preterm Infant | Growth Delay | Breast Milk Substitute IntoleranceUnited States